---
title: "Wenzhou Kangning Moves to Restore Hong Kong Public Float via Share Conversion"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/277500844.md"
description: "Wenzhou Kangning Hospital Co. (HK:2120) announced plans to restore its public float, currently at 24.11%, below the 25% minimum required by Hong Kong Listing Rules. The company will convert 9,286,359 domestic shares into H shares, increasing the public float to approximately 37.30%. The necessary filings are expected to be completed this month, with full circulation anticipated by March 2026. The hospital operates in the healthcare sector and is listed on the Hong Kong Stock Exchange, with a market cap of HK$683.9M."
datetime: "2026-03-02T15:56:53.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/277500844.md)
  - [en](https://longbridge.com/en/news/277500844.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/277500844.md)
---

# Wenzhou Kangning Moves to Restore Hong Kong Public Float via Share Conversion

### Claim 50% Off TipRanks Premium

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential

An announcement from Wenzhou Kangning Hospital Co ( (HK:2120) ) is now available.

Wenzhou Kangning Hospital has disclosed that its current public float stands at about 24.11%, slightly below the Hong Kong Listing Rules’ minimum requirement of 25% of issued shares to be held by the public. The hospital operator’s share structure consists predominantly of domestic shares, with H shares making up roughly a quarter of its issued capital, part of which is held by directors, their associates and institutional investors.

To restore compliance, the company is pursuing a full circulation plan approved in principle by Chinese regulators that will convert 9,286,359 domestic shares into H shares, which would lift the public float to around 37.30% of total issued shares after deducting repurchased but uncancelled stock. Following recent communications with the CSRC, the company expects the necessary filings to be completed this month and anticipates finishing the full circulation in March 2026, while stressing that its own and its subsidiaries’ business operations remain normal throughout this process.

**More about Wenzhou Kangning Hospital Co**

Wenzhou Kangning Hospital Co., Ltd. operates in the healthcare sector, focusing on hospital and related medical services, and is listed on the Hong Kong Stock Exchange. The company’s share capital is split between domestic shares and H shares, with a portion of its H shares held by institutional and individual public investors, alongside holdings by directors and related parties.

**Average Trading Volume:** 9,568

**Current Market Cap:** HK$683.9M

For a thorough assessment of 2120 stock, go to TipRanks’ Stock Analysis page.

### Related Stocks

- [02120.HK](https://longbridge.com/en/quote/02120.HK.md)

## Related News & Research

- [Wenzhou Kangning Sets Timeline to Restore Hong Kong Public Float Compliance](https://longbridge.com/en/news/282213956.md)
- [21:02 ETHMS Vision Inc. and Wenzhou Medical University Announce the Expansion of Their Simulation-Based Training Center During Vision China 2026](https://longbridge.com/en/news/287989528.md)
- [10:11 ETHealthcare Secondaries Manager Revelation Partners Appoints Prashant Gangwal as Partner and CFO](https://longbridge.com/en/news/287934746.md)
- [12:03 ETPRovoke Media Honors MediaSource as One of 2026's Best PR Agencies in the US](https://longbridge.com/en/news/287660023.md)
- [Wenzhou Kangning Hospital Posts Lower 2025 Profit but Stronger Cash Flow](https://longbridge.com/en/news/280206806.md)